1. Six more biotechs price public debuts just before the start of the weekend—Surprise pandemic lessons for pharma -- August FDA decisions for Axsome, Sanofi, Merck See more on our front page news
    Dismiss Notice
  2. Do you have general questions about dealing with sexual harassment or discrimination at work? Ask an attorney on this forum.
    Dismiss Notice

Layoffs by 2022

Discussion in 'Bristol-Myers Squibb' started by anonymous, May 20, 2021 at 7:52 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Upper Midwest access is almost nonexistent. MN, IA, WI... The true “cost per physician contact” is well over $10,000 per rep. Multiply that number, by the number of pod members. I’m sure there are other areas in the nation with the same challenges, but adding reps is not the answer to the problem of access.
     

  2. anonymous

    anonymous Guest

    Truth!!
     
  3. anonymous

    anonymous Guest

    Pods never made sense in oncology. Even with access, pods don’t make sense. An experienced, skilled Onc rep is worth his/her weight in gold because 2-3 overlays are unnecessary.
     
  4. anonymous

    anonymous Guest

    No one will be laid off….you might be selling a CV, UC, of Heme drug soon though
     
  5. anonymous

    anonymous Guest

    Keep on dreaming…while your pod mates are busy throwing you under the bus.
     
  6. anonymous

    anonymous Guest

    I want a package!! Let me go!!
     
  7. anonymous

    anonymous Guest

    You’ll know in August